Helios Logo

Living with Migraine? Your Experience Could Support Research

Help Evaluate a Preventive Migraine Option

Living with migraines can shape everything — from work to rest to relationships. A research study is evaluating whether a botulinum toxin injection may help prevent migraine in adults. You may qualify if your symptoms began before age 50 and have lasted 12 months or more..

Required
Required
Required
Required
Please enter 10 digits for phone number. Required when opting in to SMS.
You must consent to the privacy policy.
If you consent to SMS messages, you must provide a phone number.

Purpose of the Study

The purpose of this study is to evaluate the safety and effectiveness of a botulinum toxin injection for the prevention of migraine in adults.

Study Requirements

You may qualify if you:

    Are 18 years of age or older
    Are diagnosed with migraine for at least the last 12 months
    Your symptoms began before age 50

Potential Benefits of Participation

Icon 1

Access to new treatments that are
not yet available to the general public.

Icon 2

Personalized medical attention from
leading healthcare professionals.

Icon 3

Compensation up to $2,416.00 may be provided for study-related time and travel

Study Locations

This study is currently enrolling at the following sites:

    Helios Clinical Research - Jackson, TN (26 Stonecreek Circle, 38305)
    Helios Clinical Research - Wooster, OH (3727 Friendsville Road, 44691)

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.

Privacy Policy Current Studies Helios Highlights
We Know Time is Precious

© 2024 Helios Clinical. All rights reserved.